Skip to main content
. 2018 Jul 9;70(Suppl 3):S303–S308. doi: 10.1016/j.ihj.2018.06.022

Table 3.

Procedural characteristics of patients with aneurysm and those without aneurysm.

  Aneurysm (n = 22) Control (n = 210) p value
Valve size 0.68
20 mm (%) 0 (0.0) 3 (1.4)
23 mm (%) 10 (45.5) 68 (32.4)
26 mm (%) 7 (31.8) 77 (36.7)
29 mm (%) 5 (22.7) 62 (29.5)
Valve-in-valve (%) 0 (0.0) 6 (2.9) 1
Fluoroscopy time (minutes) 14 [12–22] 12 [9–18] 0.087
Contrast volume (ml) 144 [83–246] 100 [70–151] 0.037
Procedure duration (minutes) 67 [53–75] 58 [44–75] 0.22
Access
Trans-femoral (%) 16 (72.7) 150 (71.4) 0.9
Trans-apical (%) 5 (22.7) 56 (26.7) 0.69
Trans-subclavian (%) 1 (4.5) 4 (1.9) 0.4
General anethesia (%) 22 (100.0) 210 (100.0) 1
Moderate or severe paravalvular leak (%) 1 (4.5) 9 (4.3) 1
Device success (%) 22 (100.0) 204 (97.1) 1



Sub-group 1
  TAA (n = 11) Control (n = 210)
Trans-femoral (%) 7 (63.6) 150 (71.4) 0.73
Trans-apical (%) 3 (27.3) 56 (26.7) 1
Trans-subclavian (%) 1 (9.1) 4 (1.9) 0.23
Moderate or severe paravalvular leak (%) 0 (0.0) 9 (4.3) 1



Sub-group 2
  AAA (n = 14) Control (n = 210)
Trans-femoral (%) 10 (71.4) 150 (71.4) 1
Trans-apical (%) 3 (21.4) 56 (26.7) 1
Trans-subclavian (%) 1 (7.1) 4 (1.9) 0.28
Moderate or severe paravalvular leak (%) 1 (7.1) 9 (4.3) 0.48

Data are expressed as a number (percent) or median (interquartile range).

TAA: thoracic aortic aneurysm, AAA: abdominal aortic aneurysm.